GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 226 filers reported holding GENOMIC HEALTH INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $20,000 | -89.7% | 293 | -91.3% | 0.00% | – |
| Q2 2019 | $195,000 | -98.8% | 3,356 | -98.6% | 0.00% | -100.0% |
| Q1 2019 | $16,263,000 | -8.4% | 232,171 | -15.8% | 0.04% | -16.7% |
| Q4 2018 | $17,764,000 | +26.5% | 275,805 | +38.0% | 0.05% | +45.5% |
| Q3 2018 | $14,039,000 | +17232.1% | 199,921 | +12387.3% | 0.03% | – |
| Q2 2018 | $81,000 | +88.4% | 1,601 | +15.3% | 0.00% | – |
| Q1 2018 | $43,000 | -4.4% | 1,388 | +5.6% | 0.00% | – |
| Q4 2017 | $45,000 | +4.7% | 1,314 | -2.6% | 0.00% | – |
| Q3 2017 | $43,000 | -8.5% | 1,349 | -6.0% | 0.00% | – |
| Q2 2017 | $47,000 | +9.3% | 1,435 | +5.0% | 0.00% | – |
| Q1 2017 | $43,000 | -6.5% | 1,367 | -13.5% | 0.00% | – |
| Q4 2016 | $46,000 | -20.7% | 1,581 | -21.5% | 0.00% | – |
| Q3 2016 | $58,000 | +9.4% | 2,014 | -0.9% | 0.00% | – |
| Q2 2016 | $53,000 | – | 2,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |